Abstract:Background: Hepatitis Be antigen (HBeAg) precursor proteins, which share an identical encoding PreC/C open reading frame (PreC/C-ORF) of hepatitis B virus (HBV) core, can inhibit viral replication in vitro. The apolipoprotein B mRNA (messenger ribonucleic acid) editing enzyme catalytic polypeptide 3A (APOBEC3A) can inhibit HBV replication by interacting with the HBV core protein. The aim of the study was to explore whether the HBeAg precursor proteins can regulate HBV replication by interacting with APOBEC3A.Methods: Plasmids harboring the coding sequence of HBeAg precursor proteins (P25 and P22) and APOBEC3A were individu-ally or co-transfected into human hepatoma and embryonic kidney cells. P25, P22, and APOBEC3A expressions were quantified by Western blotting. The co-localization and interaction of P25, P22, and APOBEC3A were determined by confocal microscopy and co-immunoprecipitation (Co-IP). We constructed serial precursor proteins of HBeAg deletion mutants for further Co-IP analysis. Enzyme-linked immunosorbent assay (ELISA) was employed to evaluate the levels of HBeAg and HBsAg. HBV repli-cation intermediates from the transfected cells were detected by Southern blotting.Results: P25, P22, and APOBEC3A proteins were successfully expressed in transfected cells, and P25 or P22 protein co-localization with APOBEC3A protein in the cytoplass. Co-IP with APOBEC3A was mediated by the central region of the HBeAg precursor (amino acids 107-178). The levels of HBsAg were significantly lower in cells co-transfected with HBV e-, P22/P25, and APOBEC3A, than in cells co-transfected with HBV e-, APOBEC3A, or in cells co-transfected with HBV e-, P22/P25. The levels of HBeAg were lower in cells co-transfected with HBV e-, P22/P25, and APOBEC3A, than in cells co-transfected with HBV e-, P22/P25. Compare with cells transfected with HBV e-, APOBEC3A, or in cells co-transfected with HBV e-, P25/P22, HBV replication intermediates were lower in the cells co-transfected with HBV e-, P25, APOBEC3A, and significantly lower in the cells with HBV e-, P22, APOBEC3A.Conclusions: HBV replication can be inhibited by the interaction of P25/P22 with APOBEC3A protein in the cytoplasm.

[Expression and Activity Identification of APOBEC3A-HBc Fusion Protein].

[Cloning,expression and Activity Identification of Human Innate Immune Protein Apolipoprotein B Mrna Editing Enzyme Catalytic Subunit 3A(APOBEC3A)].

N-terminal and C-terminal Cytosine Deaminase Domain of APOBEC3G Inhibit Hepatitis B Virus Replication

Construction of Eukaryotic Expressional Vectors of APOBEC3G and the Effects on the Replication and Expression of HBV

Construction of a recombinant plasmid expressing HBV core antigen and A3C fusion protein

Cloning and Eukaryotic Expression of APOBEC3F and Its Anti-HBV Effect

Inhibition of Hepatitis B Virus Replication by APOBEC3G in Vitro and in Vivo.

HBeAg Precursor Proteins Interact with APOBEC3A and Inhibit HBV Replication

Functional analysis of the two cytidine deaminase domains in APOBEC3G.

The Expression of HCG Epitope Fused to Hepatits B Virus Core Antigen.

[Prokaryotic Expression and Immunogenicity Analysis of the Chimeric HBcAg Containing APP Beta Cleavage Site Peptide and Aβ(1-15);].

Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.

APOBEC3G Directly Binds Hepatitis B Virus Core Protein in Cell and Cell Free Systems

Human APOBEC3F Incorporation into Human Immunodeficiency Virus Type 1 Particles.

High Expression of Hepatoma Associated Antigen HAb18G in Prokaryotic Cells and Study on Its Function in Vitro

Antigenicity Assay of the Expression Product of Fusion Gene of Truncated HBV Core Gene and “a” Determinant Gene

[Expression of Anti-Hbc Single-Chain Variable Fragment Mediated by Recombinant Replication Defective Adenovirus in Vitro].

Young Investigator Session

[Expression, Purification, and Bio-Activity Analysis of Fusion Protein HBx-EGFP-TLM].

Association of Human APOBEC3 Cytidine Deaminases with the Generation of Hepatitis Virus B X Antigen Mutants and Hepatocellular Carcinoma

Expression and purification of truncated C gene combined with preS1 gene from HBV in E.coli